← Back to Search

Behavioural Intervention

rTMS for Depression

N/A
Waitlist Available
Research Sponsored by Baylor College of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 days
Awards & highlights

Study Summary

This trial is testing whether rTMS to the OFC is more effective than rTMS to the dlPFC in treating MDD.

Who is the study for?
This trial is for adults aged 18-60 with Major Depressive Disorder, as indicated by specific depression scales. Participants must understand and consent to the study's procedures, not be pregnant or nursing if female, and have no metal implants that interfere with MRI or TMS.Check my eligibility
What is being tested?
The trial tests repetitive Transcranial Magnetic Stimulation (rTMS) on a brain area called the orbitofrontal cortex in people with depression who haven't fully responded to other treatments. It aims to see if rTMS can better alleviate depressive symptoms.See study design
What are the potential side effects?
Potential side effects of rTMS may include discomfort at the stimulation site, headache, lightheadedness, seizures (very rare), and temporary hearing changes due to the noise during treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Functional connectivity of orbital frontal cortex (OFC)
Outcome Changes in MDD subjects

Trial Design

1Treatment groups
Experimental Treatment
Group I: rTMSExperimental Treatment1 Intervention
20 sessions of rTMS
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Repetitive Transcranial Magnetic Stimulation
2013
Completed Phase 3
~1170

Find a Location

Who is running the clinical trial?

Baylor College of MedicineLead Sponsor
1,001 Previous Clinical Trials
6,002,202 Total Patients Enrolled
29 Trials studying Depression
5,659 Patients Enrolled for Depression

Media Library

Repetitive Transcranial Magnetic Stimulation (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05487911 — N/A
Depression Research Study Groups: rTMS
Depression Clinical Trial 2023: Repetitive Transcranial Magnetic Stimulation Highlights & Side Effects. Trial Name: NCT05487911 — N/A
Repetitive Transcranial Magnetic Stimulation (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05487911 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this study still open?

"Unfortunately, as per the information on clinicaltrials.gov, this particular trial is not presently enrolling patients and has not done so since August 2nd 2022. However, 825 other medical studies are actively seeking candidates at present."

Answered by AI

What criteria must an individual meet in order to participate in this clinical experiment?

"This clinical trial is accepting applicants that have major depressive disorder and are between the ages of 18-64. Approximately 50 individuals will be included in this research endeavor."

Answered by AI

Is it possible for persons younger than sixty to qualify as participants in this trial?

"Applicants to this medical trial must be between 18 and 64 years old. There are 106 studies that focus on minors, while 594 trials exist for people over 65."

Answered by AI
~30 spots leftby Aug 2025